SA
Log In
TEAM
OverviewIntelligenceChart
Signal
Mixed1↑1↓
Price
1↓
Move↓-2.70%Negative session
Volume
1→
Volume→0.7× avgNormal activity
Technical
1↑
RSI↑RSI 56Momentum positive
PRICE
Prev Close
70.49
Open
69.59
Day Range66.55 – 69.59
66.55
69.59
52W Range56.01 – 232.36
56.01
232.36
7% of range
VOLUME & SIZE
Avg Volume
7.3M
FUNDAMENTALS
P/E Ratio
-95.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
2.04
High vol
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +25% YoY · 84% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 0.7 (low) · FCF $4.59/sh
Lean Bullish
Key MetricsTTM
Market Cap$18.04B
Revenue TTM$6.19B
Net Income TTM-$216.81M
Free Cash Flow$1.20B
Gross Margin84.0%
Net Margin-3.5%
Operating Margin-3.7%
Return on Equity-16.7%
Return on Assets-3.8%
Debt / Equity1.41
Current Ratio0.70
EPS TTM$-0.83
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong1 watch3 concern
43/100
Liquidity
0.70Concern
Leverage
1.41Watch
Coverage
8.4xStrong
ROE
-16.7%Concern
ROIC
-9.2%Concern
Cash
$2.5BStrong
ANALYST COVERAGE26 analysts
BUY
▲ +89.5%upside to target
L $90.00
Med $130.00consensus
H $200.00
Buy
2285%
Hold
415%
22 Buy (85%)4 Hold (15%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
5/10
Technicals
●
RSI RangeRSI 56 — Bullish momentum
✓
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 0.70 — liquidity risk
✗

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 2, 2026
Tomorrow
DEx-Dividend DateJul 30, 2026
In 90 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

▼ DowntrendDeath Cross · 50D trails 200D by 36.2%

-30.3% vs SMA 50 · -55.5% vs SMA 200

Momentum

RSI56.0
Positive momentum, not extended
MACD-6.37
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$232.4+238.8%
EMA 200
$148.3+116.1%
EMA 50
$96.80+41.1%
Current
$68.59
52W Low
$56.01-18.3%
52-Week RangeNear 52-week low
$56.017th %ile$232.4
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 24 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$5.2B
$5.1B–$5.2B
—$3.54—
±6%
High20
FY2026(current)
$6.4B
$6.3B–$6.4B
▲ +22.8%$4.76▲ +34.3%
±7%
High23
FY2027
$7.5B
$7.3B–$7.6B
▲ +17.5%$5.54▲ +16.5%
±9%
High24
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryTEAM
Last 8Q
-1.4%avg beat
Beat 7 of 8 quartersMissed 1↑ Estimates rising
+14%
Q3'24
+21%
Q4'24
+27%
Q1'25
+7%
Q2'25
+18%
Q3'25
+24%
Q4'25
+6%
Q1'26
-128%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
Analysts turning cautious
30d▲ 0▼ 1
90d▲ 0▼ 1
CitigroupBuy → Mixed
Apr 17
DOWNGRADE
CitigroupBuy → Positive
Oct 14
UPGRADE
Cantor FitzgeraldNeutral → Overweight
Apr 2
UPGRADE
BMO CapitalMarket Perform → Outperform
Jan 10
UPGRADE
KeyBancOverweight
Nov 1
UPGRADE
OTR GlobalPositive → Mixed
Oct 11
DOWNGRADE
Raymond JamesMarket Perform → Outperform
Oct 1
UPGRADE
Piper SandlerNeutral → Overweight
Jul 2
UPGRADE
BarclaysOverweight
Apr 11
UPGRADE
OTR GlobalPositive
Jan 10
UPGRADE
JefferiesHold → Buy
Jan 5
UPGRADE
Piper SandlerNeutral
Nov 4
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Liu GeneChief Accounti…
$2K
Feb 19
SELL
Liu GeneChief Accounti…
$661
Feb 19
SELL
Liu GeneChief Accounti…
$2K
Feb 19
SELL
Liu GeneChief Accounti…
$167
Feb 19
SELL
Duffy BrianChief Revenue …
$12K
Feb 19
SELL
Duffy BrianChief Revenue …
$43K
Feb 19
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Pictet Asset Management Holding SA
5.0M▲
2
SG Americas Securities, LLC
906K▲
3
Assenagon Asset Management S.A.
302K▼
4
Y-Intercept (Hong Kong) Ltd
242K▲
5
Fisher Funds Management LTD
223K▼
6
ProShare Advisors LLC
215K▼
7
SBI Securities Co., Ltd.
171K▲
8
USS Investment Management Ltd
170K▲
News & Activity

TEAM News

20 articles · 4h ago

About

atlassian is a leading provider of collaboration, development, and issue tracking software for teams. with over 50,000 global customers (including 85 of the fortune 100), we’re advancing the power of collaboration with products including jira, confluence, hipchat, and bitbucket. driven by honest values, an amazing culture, and consistent revenue growth, we’re out to unleash the potential of every team. for more information, visit https://www.atlassian.com/company

Country
United Kingdom

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance